Trial intelligence / Profile preview

GH and Electrical Stimulation for Muscle Repair

NCT05746650Recruiting

Sponsor
Bispebjerg and Frederiksberg Hospital
Start
Feb 2023
Primary completion
Jun 2027
Modality
Hormone, rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

Randomised, double-blind trial of somatropin in muscle injury (4 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Difference in muscle and myotendinous junction protein synthesis in regenerating vs. control muscle at 2 years. Started Feb 2023; status: recruiting.

02

Drugs

somatropin
03

Conditions

muscle injury

Beyond the preview

Go deeper on NCT05746650.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05746650.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call